Cargando…

Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy

BACKGROUND: Among its pleiotropic properties, gender-affirming hormone therapy (GHT) affects regional brain volumes. The hypothalamus, which regulates neuroendocrine function and associated emotional and cognitive processes, is an intuitive target for probing GHT effects. We sought to assess changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Konadu, Melisande E., Reed, Murray B., Kaufmann, Ulrike, Handschuh, Patricia A., Spurny-Dworak, Benjamin, Klöbl, Manfred, Schmidt, Clemens, Godber, Godbersen, M., Briem, Elisa, Seiger, René, Baldinger-Melich, Pia, Kranz, Georg S., Lanzenberger, Rupert, Spies, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CMA Impact Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521920/
https://www.ncbi.nlm.nih.gov/pubmed/37751919
http://dx.doi.org/10.1503/jpn.230017
_version_ 1785110245994921984
author Konadu, Melisande E.
Reed, Murray B.
Kaufmann, Ulrike
Handschuh, Patricia A.
Spurny-Dworak, Benjamin
Klöbl, Manfred
Schmidt, Clemens
Godber
Godbersen, M.
Briem, Elisa
Seiger, René
Baldinger-Melich, Pia
Kranz, Georg S.
Lanzenberger, Rupert
Spies, Marie
author_facet Konadu, Melisande E.
Reed, Murray B.
Kaufmann, Ulrike
Handschuh, Patricia A.
Spurny-Dworak, Benjamin
Klöbl, Manfred
Schmidt, Clemens
Godber
Godbersen, M.
Briem, Elisa
Seiger, René
Baldinger-Melich, Pia
Kranz, Georg S.
Lanzenberger, Rupert
Spies, Marie
author_sort Konadu, Melisande E.
collection PubMed
description BACKGROUND: Among its pleiotropic properties, gender-affirming hormone therapy (GHT) affects regional brain volumes. The hypothalamus, which regulates neuroendocrine function and associated emotional and cognitive processes, is an intuitive target for probing GHT effects. We sought to assess changes to hypothalamus and hypothalamic subunit volumes after GHT, thereby honouring the region’s anatomical and functional heterogeneity. METHODS: Individuals with gender dysphoria and cisgender controls underwent 2 MRI measurements, with a median interval of 145 days (interquartile range [IQR] 128.25–169.75 d, mean 164.94 d) between the first and second MRI. Transgender women (TW) and transgender men (TM) underwent the first MRI before GHT and the second MRI after approximately 4.5 months of GHT, which comprised estrogen and anti-androgen therapy in TW or testosterone therapy in TM. Hypothalamic volumes were segmented using FreeSurfer, and effects of GHT were tested using repeated-measures analysis of covariance. RESULTS: The final sample included 106 participants: 38 TM, 15 TW, 32 cisgender women (CW) and 21 cisgender men (CM). Our analyses revealed group × time interaction effects for total, left and right hypothalamus volume, and for several subunits (left and right inferior tubular, left superior tubular, right anterior inferior, right anterior superior, all p(corr) < 0.01). In TW, volumes decreased between the first and second MRI in these regions (all p(corr) ≤ 0.01), and the change from the first to second MRI in TW differed significantly from that in CM and CW in several subunits (p(corr) < 0.05). LIMITATIONS: We did not address the influence of transition-related psychological and behavioural changes. CONCLUSION: Our results suggest a subunit-specific effect of GHT on hypothalamus volumes in TW. This finding is in accordance with previous reports of positive and negative effects of androgens and estrogens, respectively, on cerebral volumes.
format Online
Article
Text
id pubmed-10521920
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher CMA Impact Inc.
record_format MEDLINE/PubMed
spelling pubmed-105219202023-09-27 Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy Konadu, Melisande E. Reed, Murray B. Kaufmann, Ulrike Handschuh, Patricia A. Spurny-Dworak, Benjamin Klöbl, Manfred Schmidt, Clemens Godber Godbersen, M. Briem, Elisa Seiger, René Baldinger-Melich, Pia Kranz, Georg S. Lanzenberger, Rupert Spies, Marie J Psychiatry Neurosci Research Paper BACKGROUND: Among its pleiotropic properties, gender-affirming hormone therapy (GHT) affects regional brain volumes. The hypothalamus, which regulates neuroendocrine function and associated emotional and cognitive processes, is an intuitive target for probing GHT effects. We sought to assess changes to hypothalamus and hypothalamic subunit volumes after GHT, thereby honouring the region’s anatomical and functional heterogeneity. METHODS: Individuals with gender dysphoria and cisgender controls underwent 2 MRI measurements, with a median interval of 145 days (interquartile range [IQR] 128.25–169.75 d, mean 164.94 d) between the first and second MRI. Transgender women (TW) and transgender men (TM) underwent the first MRI before GHT and the second MRI after approximately 4.5 months of GHT, which comprised estrogen and anti-androgen therapy in TW or testosterone therapy in TM. Hypothalamic volumes were segmented using FreeSurfer, and effects of GHT were tested using repeated-measures analysis of covariance. RESULTS: The final sample included 106 participants: 38 TM, 15 TW, 32 cisgender women (CW) and 21 cisgender men (CM). Our analyses revealed group × time interaction effects for total, left and right hypothalamus volume, and for several subunits (left and right inferior tubular, left superior tubular, right anterior inferior, right anterior superior, all p(corr) < 0.01). In TW, volumes decreased between the first and second MRI in these regions (all p(corr) ≤ 0.01), and the change from the first to second MRI in TW differed significantly from that in CM and CW in several subunits (p(corr) < 0.05). LIMITATIONS: We did not address the influence of transition-related psychological and behavioural changes. CONCLUSION: Our results suggest a subunit-specific effect of GHT on hypothalamus volumes in TW. This finding is in accordance with previous reports of positive and negative effects of androgens and estrogens, respectively, on cerebral volumes. CMA Impact Inc. 2023-09-26 /pmc/articles/PMC10521920/ /pubmed/37751919 http://dx.doi.org/10.1503/jpn.230017 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Research Paper
Konadu, Melisande E.
Reed, Murray B.
Kaufmann, Ulrike
Handschuh, Patricia A.
Spurny-Dworak, Benjamin
Klöbl, Manfred
Schmidt, Clemens
Godber
Godbersen, M.
Briem, Elisa
Seiger, René
Baldinger-Melich, Pia
Kranz, Georg S.
Lanzenberger, Rupert
Spies, Marie
Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
title Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
title_full Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
title_fullStr Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
title_full_unstemmed Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
title_short Changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
title_sort changes to hypothalamic volume and associated subunits during gender-affirming hormone therapy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521920/
https://www.ncbi.nlm.nih.gov/pubmed/37751919
http://dx.doi.org/10.1503/jpn.230017
work_keys_str_mv AT konadumelisandee changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT reedmurrayb changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT kaufmannulrike changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT handschuhpatriciaa changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT spurnydworakbenjamin changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT kloblmanfred changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT schmidtclemens changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT godber changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT godbersenm changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT briemelisa changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT seigerrene changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT baldingermelichpia changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT kranzgeorgs changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT lanzenbergerrupert changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy
AT spiesmarie changestohypothalamicvolumeandassociatedsubunitsduringgenderaffirminghormonetherapy